ArticleProbiotics and antimicrobial proteins2026
The Effect of Synbiotic on Ovarian Function and Quality in Cisplatin-induced Premature Ovarian Failure Wistar Rats.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pathogenic mechanisms and comprehensive therapeutic strategies of ovarian aging: targeting gut microbiota.Frontiers in microbiology · 2026Review
- The effects of probiotics, prebiotics, and synbiotics on aversive memory in a premature ovarian failure model in rat.Physiological reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Infertility is a significant global challenge, affecting approximately 15% of couples. Premature Ovarian Failure (POF) is one of the primary causes of female infertility. Some new evidence suggests that gut microbiota influences ovarian function. This study investigated the therapeutic effects of probiotics, prebiotics, and synbiotics on POF. In the present experimental animal study, thirty Wistar rats were randomly divided into five groups: (1) Control group, (2) POF group (cisplatin-induced model), (3) POF-Probiotic group (daily gavage of Saccharomyces boulardii at 1 × 10⁹ CFU), (4) POF-Prebiotic group (daily gavage of inulin at 500 mg/kg), and (5) POF-Synbiotic group (a combination of prebiotic and probiotic). After 28 days, the animals were sacrificed, blood samples were collected, and the ovaries were removed for histological assessment, oxidative stress evaluation, and RT-PCR analysis. In all. Treatment groups in body weight, ovarian tissue index, and folliculogenesis were better than the POF group. Oxidative stress was significantly lower in the synbiotic-treated group compared to other treatments and POF groups. Moreover, synbiotic treatment enhanced the expression of genes involved in folliculogenesis and inhibited apoptosis-related gene expression compared to the POF group. Synbiotic supplementation effectively reduced oxidative stress and ovarian apoptosis while promoting folliculogenesis via upregulation of key genes involved in this process. Consequently, synbiotics may mitigate some of the adverse effects of POF and improve ovarian function in affected rats.
Indexed as
Identifiers
40762782What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.